TRIM59 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.37080005522006E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.61999999999507E-05 |
Normal-vs-Stage2 |
9.339100E-03 |
Normal-vs-Stage3 |
1.595700E-03 |
Normal-vs-Stage4 |
2.729700E-02 |
Stage1-vs-Stage2 |
2.265800E-01 |
Stage1-vs-Stage3 |
3.068200E-02 |
Stage1-vs-Stage4 |
1.717840E-01 |
Stage2-vs-Stage3 |
1.796350E-01 |
Stage2-vs-Stage4 |
4.343800E-01 |
Stage3-vs-Stage4 |
7.016800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.2091000008202E-08 |
Normal-vs-AfricanAmerican |
4.411400E-04 |
Normal-vs-Asian |
4.345900E-02 |
Caucasian-vs-AfricanAmerican |
7.256400E-01 |
Caucasian-vs-Asian |
2.370600E-01 |
AfricanAmerican-vs-Asian |
1.727600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.65600000004529E-06 |
Normal-vs-Female |
3.44430000076557E-08 |
Male-vs-Female |
1.841180E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.715200E-03 |
Normal-vs-Extreme_Weight |
2.619000E-03 |
Normal-vs-Obese |
2.09349999999997E-05 |
Normal-vs-Extreme_Obese |
2.049400E-01 |
Normal_Weight-vs-Extreme_Weight |
3.173000E-01 |
Normal_Weight-vs-Obese |
1.022410E-01 |
Normal_Weight-vs-Extreme_Obese |
6.170800E-01 |
Extreme_Weight-vs-Obese |
8.664100E-03 |
Extreme_Weight-vs-Extreme_Obese |
9.907200E-01 |
Obese-vs-Extreme_Obese |
8.848100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.740800E-03 |
Normal-vs-Age(41-60Yrs) |
4.60960000170374E-08 |
Normal-vs-Age(61-80Yrs) |
7.90099999999905E-05 |
Normal-vs-Age(81-100Yrs) |
1.277810E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.294300E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.535610E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.455100E-03 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.351900E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.285800E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.476400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.53350000001262E-06 |
Normal-VS-Type2 PRCC |
4.155800E-03 |
Normal-VS-KIRP CIMP |
1.582010E-04 |
Normal-VS-Unclassified PRCC |
4.027700E-04 |
Type1 PRCC-VS-Type2 PRCC |
4.672600E-01 |
Type1 PRCC-VS-KIRP CIMP |
4.175400E-04 |
Type1 PRCC-VS-Unclassified PRCC |
1.030150E-01 |
Type2 PRCC-VS-KIRP CIMP |
3.756300E-04 |
Type2 PRCC-VS-Unclassified PRCC |
3.842200E-02 |
KIRP CIMP-VS-Unclassified PRCC |
7.560200E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.017800E-03 |
Normal-vs-N1 |
1.952990E-04 |
Normal-vs-N2 |
4.487400E-01 |
N0-vs-N1 |
1.558620E-03 |
N0-vs-N2 |
6.515600E-01 |
N1-vs-N2 |
2.130000E-01 |
|
|